Myomo, Inc. (MYO) stock
MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3030% below fair value
$0.92−0.10 (-9.91%)
Close on Nov 17, 2026Market cap $36.40MP/E –Yield –
Myomo ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.87M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.87M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.40M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.36M | – |
See a number that looks wrong?